asd  

XTL BIOPHARMACEUTICALS LTD ANNOUNCES IT SUBMITTED AN APPLICATION TO THE FOOD AND DRUG ADMINISTRATION (FDA) REQUESTING THAT ITS EPO DRUG BE GRANTED ORPHAN DRUG STATUS